BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31025572)

  • 1. The Role of Factor V Leiden, Prothrombin G20210A, and MTHFR C677T Mutations in Neonatal Cerebral Sinovenous Thrombosis.
    Garrido-Barbero M; Arnaez J; Loureiro B; Arca G; Agut T; Garcia-Alix A
    Clin Appl Thromb Hemost; 2019; 25():1076029619834352. PubMed ID: 31025572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
    Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
    J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombophilic polymorphisms - factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T - in Tunisian patients with cerebral venous thrombosis.
    Ben Salem-Berrabah O; Fekih-Mrissa N; N'siri B; Ben Hamida A; Benammar-Elgaaied A; Gritli N; Mrissa R
    J Clin Neurosci; 2012 Sep; 19(9):1326-7. PubMed ID: 22721898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factor V Leiden, FII G20210A, MTHFR C677T mutations as risk factors for venous thrombosis during pregnancy and puerperium].
    Dordević V; Rakićević L; Spasić M; Miković D; Kovać M; Radojković D
    Vojnosanit Pregl; 2005 Mar; 62(3):201-5. PubMed ID: 15790048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
    Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
    Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
    Mueller T; Marschon R; Dieplinger B; Haidinger D; Gegenhuber A; Poelz W; Webersinke G; Haltmayer M
    J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral venous and sinus thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden.
    Rahimi Z; Mozafari H; Bigvand AH; Doulabi RM; Vaisi-Raygani A; Afshari D; Razazian N; Rezaei M
    Clin Appl Thromb Hemost; 2010 Aug; 16(4):430-4. PubMed ID: 19703820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey.
    Kabukcu S; Keskin N; Keskin A; Atalay E
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):166-71. PubMed ID: 17456626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of thrombophilic genetic mutations in patients with Sheehan's syndrome: is thrombophilia responsible for the pathogenesis of Sheehan's syndrome?
    Gokalp D; Tuzcu A; Bahceci M; Ayyildiz O; Yurt M; Celik Y; Alpagat G
    Pituitary; 2011 Jun; 14(2):168-73. PubMed ID: 21107737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.
    Rahimi Z; Nomani H; Mozafari H; Vaisi-Raygani A; Madani H; Malek-Khosravi S; Parsian A
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):252-6. PubMed ID: 19349859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease.
    Almawi WY; Ameen G; Tamim H; Finan RR; Irani-Hakime N
    J Thromb Thrombolysis; 2004 Jun; 17(3):199-205. PubMed ID: 15353918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
    Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of factor V, prothrombin, MTHFR, and PAI-1 genotypes in childhood cerebral thrombosis.
    Ozyurek E; Balta G; Degerliyurt A; Parlak H; Aysun S; Gürgey A
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):154-60. PubMed ID: 17456624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of three prothrombotic polymorphisms among Palestinians: factor V G1691A, factor II G20210A and methylenetetrahydrofolate reductase C677T.
    Hussein AS
    J Thromb Thrombolysis; 2012 Oct; 34(3):383-7. PubMed ID: 22528331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MTHFR (C677T, A1298C), FV Leiden polymorphisms, and the prothrombin G20210A mutation in arterial ischemic stroke among young tunisian adults.
    M'barek L; Sakka S; Meghdiche F; Turki D; Maalla K; Dammak M; Kallel C; Mhiri C
    Metab Brain Dis; 2021 Mar; 36(3):421-428. PubMed ID: 33400068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians.
    Eid SS; Rihani G
    Clin Lab Sci; 2004; 17(4):200-2. PubMed ID: 15559724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombophilic polymorphisms--factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations--and preterm birth.
    Resch B; Gallistl S; Kutschera J; Mannhalter C; Muntean W; Mueller WD
    Wien Klin Wochenschr; 2004 Sep; 116(17-18):622-6. PubMed ID: 15515881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of factor V Leiden G1691A, MTHFR C677T, and prothrombin G20210A among Asian Indian sickle cell patients.
    Pandey SK; Meena A; Kishor K; Mishra RM; Pandey S; Saxena R
    Clin Appl Thromb Hemost; 2012 Jun; 18(3):320-3. PubMed ID: 22084413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
    Nishank SS; Singh MP; Yadav R
    Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T and A1298C Mutations in Patients With Sickle Cell Disease in Tunisia.
    Belhaj Nefissi R; Doggui R; Ouali F; Messaoud T; Gritli N
    Hemoglobin; 2018 Mar; 42(2):96-102. PubMed ID: 30200836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.